Table 3.
A summary of clinical trials of low FODMAPs diet
Ref # | Design | Study population | Intervention | Time | Outcome measures | Symptom improvement | Compliance | Additional Outcomes |
---|---|---|---|---|---|---|---|---|
32 | Non- randomized, retrospective observational | IBS patients; standard diet group=39, low FODMAP group=43 | Low FODMAP or NICE dietary guidelines (fiber, probiotics, exclusion diets), breath tests. | 2–6 m | Change in symptoms (7-point Likert scale) and diet satisfaction (5-point Likert scale). | Composite symptom score improved in 86% vs. 49% (low FODMAP vs. standard group) (P<0.001). | 84% of low FODMAP group assessed; 64% adhered strictly, 30% ~ 50% of the time. | Satisfaction= 76% vs. 54% (low FODMAP vs. standard group, P=0.038). |
27 | Double blind, randomized placebo controlled quadruple-armed | IBS (12 IBS-D, 5 IBS-C and 8 IBS-M) with FM; responded to low FODMAP diet for 3 months | Patients received 3 doses of either fructans (7,14, or 19 g/3 days), fructose (14,28,50 g/3 days), fructans + fructose or glucose (7,14,20g/8 days) | 22 w | Daily symptom assessments and adherence to diet through daily food diaries | 70% on fructose, 77% on fructans and 79% on fructose + fructans had symptom relapse (gas, bloating, pain) compared to 14% on glucose (P<0.001) | Diet adherence was > 95%. | Higher doses of fructose and/or fructans associated with more severe symptoms (P<0.01) but not with glucose. |
33 | Non- randomized prospective observational | 90 IBS patients referred for lactose and fructose breath testing | All received high and low FODMAPs lists, recipes, reintroduction of restricted foods guidelines and consultation with dietitian. | Mean total 15.7 m | GI symptom questionnaire (7 point Likert) at baseline and 6 weeks. Adherence and opinion of diet. | Improvement (P<0.05) in all symptoms except feeling full, burping and passage of mucus. | 76% adherent 50% of the time or more. | Satisfied= 77%; easy to follow diet= 50%. Presence of FM strongly associated with efficacy. |
34 | Randomized controlled single-blind crossover | 30 IBS patients (10 IBS-D, 13 IBC-C, 5 IBS-M and 2 IBS-U) vs. 8 healthy controls | Average of 3.05 g FODMAP/day. Control diet = average of 23.7 g FODMAP per day. | 21 d per diet | Daily food records and symptoms; differences in individual & overall symptoms, King’s stool chart & fecal water content. | Improvement in 70% of patients, including 70% with FM, 60% without FM and 75% no prior breath test. Pain, bloating and dissatisfaction with stool consistency improved (P<0.001) especially IBS-D. | Adherent= at least 17/21 days (80%); control diet=100%; low FODMAP diet= 80%. | None. |
35 | Randomized single-blind crossover study | 15 IBS patients (4 IBS-D, 8 IBS- C, 2 IBS-M, 2 IBS-U) vs. 15 healthy controls | Low (9 g) or high (50 g) FODMAP for 2 days. Breath samples collected on day 2 of study. | 2 d per diet | Breath H2, CH4 and symptoms measured on a Likert 0 to 3 scale | Abdominal pain, bloating, gas, heartburn, nausea and lethargy reduced in IBS patients when on low FODMAP diet. Gas lower in healthy patients on the low FODMAP diet. | Not assessed. | AUC for H2 (not CH4) higher with high vs. low FODMAP diet in both normal and IBS. |
Ref#; references, IBS-D, C, M; irritable bowel syndrome-diarrhea, constipation and mixed type, FM; fructose malabsorption, H2; hydrogen, CH4; methane, AUC; area under the curve